Isoptin

Verapamil Hydrochloride, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral tablet for oral use. It is employed to manage hypertension, angina pectoris, and certain supraventricular tachyarrhythmias in adult patients. GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin, a calcium channel blocker, is indicated for several cardiovascular conditions. - Hypertension: lowers elevated blood pressure by vasodilation and reduced cardiac contractility. - Angina pectoris: relieves chest pain by decreasing myocardial oxygen demand. - Supraventricular tachyarrhythmias: controls abnormal rapid heart rhythms by slowing conduction through the AV node.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness or light‑headedness: related to blood pressure reduction. - Constipation: reduced gastrointestinal motility. - Nausea: occasional upset stomach. - Peripheral edema: swelling of lower limbs. - Flushing: transient warmth and redness.

Serious or Rare Side Effects: - Bradycardia: markedly slow heart rate requiring monitoring. - Hypotension: severe drop in blood pressure. - AV block: impaired atrioventricular conduction. - Heart failure exacerbation: worsening of cardiac function. - Hepatic dysfunction: abnormal liver enzymes. - Severe allergic reactions: rash, swelling, or anaphylaxis.

Before initiating therapy, consider the following safety measures. - Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Cardiac function assessment: evaluate for existing heart block or heart failure. - Concomitant drug review: check for interactions that may increase verapamil levels. - Hepatic impairment caution: adjust use in patients with liver disease. - Discontinuation guidance: avoid abrupt cessation to prevent rebound hypertension. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Verapamil may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Beta‑blockers: combined use can cause profound bradycardia. - Digoxin: verapamil raises digoxin concentrations, increasing toxicity risk. - Diltiazem: additive effects on cardiac conduction and contractility. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise verapamil plasma levels. - Strong CYP3A4 inducers (e.g., rifampin): can reduce therapeutic effectiveness.

Moderate Interactions (Monitor Closely): - NSAIDs: may blunt antihypertensive response. - Diuretics: monitor electrolytes and blood pressure. - CYP3A4‑metabolised statins (e.g., simvastatin): increased risk of myopathy. - Antacids: may affect oral absorption of verapamil. - Alcohol: can enhance hypotensive effects.